Dr. Alfred Rosenbaum, MD

Dr. Rosenbaum practices at Southside Faculty Medical Affiliates University Faculty Practice Corp in New Hyde Park, New York.

Dr. Rosenbaum's NPI, 1790881852, was assigned on September 16, 2006. Dr. Rosenbaum holds New York license 116442.

Dr. Rosenbaum's primary practice is Southside Faculty Medical Affiliates University Faculty Practice Corp, at 2000 Marcus Ave, New Hyde Park, NY 11042 in Nassau County. The practice phone is (516) 266-3456.

Dr. Rosenbaum's primary practice is Southside Faculty Medical Affiliates University Faculty Practice Corp in New Hyde Park, New York. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Rosenbaum to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenbaum practices, 3 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Rosenbaum's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Rosenbaum is licensed in New York.

CMS data shows 2,097 Medicare services from Dr. Rosenbaum across 13 procedure codes in 2024, for 1,112 Medicare patients. Medicare paid $187,161 for them. Every service was in an office.

CMS counts 1,112 Medicare patients who saw Dr. Rosenbaum in 2024. The largest group is 65 to 74, with 510 patients. 75% of them have high cholesterol, and 55% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rosenbaum's median patient age at 70, with 83% women.

In 2024, Dr. Rosenbaum wrote 32 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $237 in total drug cost. In 2020, CMS named 59 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rosenbaum for performance year 2024, reported individually. Dr. Rosenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 49 general payments to Dr. Rosenbaum from 19 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $153.